Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario de Vigo (24)

2026

  1. Clinical Factors Associated With Current Relevance in Allergic Contact Dermatitis: Development of Predictive Models Based on Data From the Spanish Contact Dermatitis Register (REIDAC)

    Contact Dermatitis, Vol. 94, Núm. 6, pp. 614-623

  2. Epidemiological, Clinical and Allergic Profile of Patients With Dyshidrotic Eczema (Acute and Recurrent Vesicular Dermatitis): Evaluation of the Spanish Registry of Research in Contact Dermatitis and Cutaneous Allergy (REIDAC)

    Contact Dermatitis

  3. Influence of the level of education on cognitive function in Parkinson’s disease

    Journal of Neural Transmission, Vol. 133, Núm. 4, pp. 663-681

  4. Is there a window of opportunity in the treatment of giant cell arteritis with tocilizumab? Multicenter study of 471 patients

    Seminars in Arthritis and Rheumatism, Vol. 78

  5. Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication–Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study

    Journal of Clinical Oncology

  6. Safety of sonidegib in elderly patients with locally advanced basal cell carcinoma: A multicentre study

    Journal of the European Academy of Dermatology and Venereology

2025

  1. Correction to: Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline (Journal of Neurology, (2025), 272, 3, (246), 10.1007/s00415-024-12808-0)

    Journal of Neurology

  2. Current status of the immunogenicity of enzyme replacement therapy in fabry disease

    Orphanet Journal of Rare Diseases , Vol. 20, Núm. 1

  3. Decreasing prevalence and cumulative incidence of scleroderma renal crisis over time: Associated factors identified from the RESCLE registry

    Rheumatology, Vol. 64, Núm. 12, pp. 6201-6212

  4. Dysphagia in Parkinson´s disease. A 5-year follow-up study

    Neurological Sciences, Vol. 46, Núm. 6, pp. 2637-2653

  5. Heterogeneity of cognitive progression and clinical predictors in Parkinson’s disease–subjective cognitive decline

    Journal of Neurology, Vol. 272, Núm. 3

  6. Patch test results to the Spanish baseline patch test series according to age groups: A multicentric prospective study from 2019 to 2023

    Contact Dermatitis, Vol. 92, Núm. 2, pp. 120-130

  7. Real world outcomes of momelotinib in myelofibrosis patients with anemia: results from the MOMGEMFIN study

    Blood Cancer Journal

2024

  1. A Phase III Randomized Controlled Trial of Plitidepsin, a Marine-Derived Compound, in Hospitalized Adults With Moderate COVID-19

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, Vol. 79, Núm. 4, pp. 910-919

  2. Levodopa-Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study

    Movement Disorders Clinical Practice, Vol. 11, Núm. 7, pp. 830-849

  3. Spanish cardiac catheterization and coronary intervention registry. 33rd official report of the Interventional Cardiology Association of the Spanish Society of Cardiology (1990-2023)

    Revista Espanola de Cardiologia, Vol. 77, Núm. 11, pp. 936-946

2023

  1. IP-10 and MIG are sensitive markers of early virological response to HIV-1 integrase inhibitors

    Frontiers in Immunology, Vol. 14

  2. Interleukin 18 (IL-18) and IL-3 in Extracellular Vesicles: Biomarkers for Durable Elite Control of HIV-1

    Journal of Infectious Diseases

  3. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 19, Núm. 5, pp. e450-e452

2022

  1. Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort

    HIV Medicine, Vol. 23, Núm. 8, pp. 825-836